Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda

Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda

Background: High-risk human papillomavirus (hrHPV) may cause more than 99% of cervical cancers worldwide. Little is known about performance differences in tests for hrHPV. Objective: This study analysed agreement for detection of hrHPV between the established, clinically validated Xpert HPV assay a...

Full description

Bibliographic Details
Main Authors: Anthere Murangwa, Kanan T. Desai, Julia C. Gage, Gad Murenzi, Patrick Tuyisenge, Faustin Kanyabwisha, Aimable Musafili, Gallican Kubwimana, Leon Mutesa, Kathryn Anastos, Hae-Young Kim, Philip E. Castle
Format: Article
Language:English
Published: AOSIS 2022-10-01
Series:African Journal of Laboratory Medicine
Subjects:
xpert hpv assay
ampfire hpv genotyping assay
high-risk human papillomavirus types
women living with hiv
cervical cancer screening
Online Access:https://ajlmonline.org/index.php/ajlm/article/view/1827

Internet

https://ajlmonline.org/index.php/ajlm/article/view/1827

Similar Items